Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Oral NAD+ Precursor Ranges from Published Trials Precursor Nicotinamide Riboside (NR) Dose 300-1,000 mg Frequency Daily Trial signal Multiple human RCTs raised blood NAD+ with favorable tolerability
Botox is a trademark of Allergan Inc .
Most published outcomes are measured at 26 weeks (Phase 2) or 68 weeks (Phase 3 REDEFINE)
The reverse billing 90460 without documented counseling creates the same compliance risk
US$ 23.74
US$ 26.94
US$ 28.66
